Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zentiva
Manufacturing
PE firm strikes €4.1B deal for Czech generics maker Zentiva: FT
Zentiva was Sanofi’s European generics business from 2008 until 2018, when Sanofi sold the manufacturer to Advent International for 1.9 billion euros.
Fraiser Kansteiner
Sep 11, 2025 10:25am
Zentiva inks €220M deal for former AstraZeneca GI drug in Europe
May 22, 2025 1:30am
Poland's largest pharma eyes Zentiva buyout: report
Jan 21, 2022 11:50am
Advent's Zentiva grabs Romanian drugmaker Labormed from Alvogen
Oct 28, 2019 10:38am
Private equity firm snatches another Sanofi castoff
Sep 11, 2019 10:11am
Sanofi, Advent shake hands on $2.2B European generics sale
Jun 28, 2018 11:00am